At a glance
ClinicalIndex Comparison RecordN/ACompleted· 368 enrolled
Drug / intervention
Hyaluronic Acid and TH (Cingal®) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee
In Brief
A clinical study evaluating Hyaluronic Acid and TH (Cingal®), Hyaluronic Acid (Monovisc®), and 1 other intervention for Knee Osteoarthritis. Completed, enrolled 368 participants across 27 sites in 5 countries.
Detailed Summary
The purpose of this study is to see if a single injection of Cingal into the knee provides safe relief of pain caused by osteoarthritis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesBulgaria, Canada, Czechia, Hungary, Poland
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJun 2013
First PostedJul 2013
Primary CompletionMay 2014
Study CompletionSep 2014
TodayJul 2026
First PostedJul 3, 2013
Enrollment StartJun 1, 2013
Primary CompletionMay 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.0 years ago
Interventions
Hyaluronic Acid and TH (Cingal®)device
Injection into knee
Hyaluronic Acid (Monovisc®)device
Injection into knee
Salinedevice
Saline placebo packaged to look identical to comparator syringes. Injection into knee.